Notes
The study received financial support from Merck & Co Inc.
Reference
Sharman Moser S, et al. Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis. Annals of Pharmacotherapy : 18 Jan 2016. Available from: URL: http://doi.org/10.1177/1060028015626935
Rights and permissions
About this article
Cite this article
Bisphosphonate non-adherence a common, costly issue. PharmacoEcon Outcomes News 745, 11 (2016). https://doi.org/10.1007/s40274-016-2752-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2752-7